Fibronectin gene polymorphisms influence type II mixed cryoglobulinemia clinical manifestations

被引：0
|
作者：
Fabris, M [1 ]
De Marchi, G [1 ]
Sacco, S [1 ]
De Vita, S [1 ]
机构：
[1] Univ Udine, Sch Med, Clin Rheumatol, I-33100 Udine, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 263
页数：1
相关论文
共 50 条
  • [1] Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia
    Fabris, M.
    Quartuccio, L.
    Salvin, S.
    Pozzato, G.
    De Re, V.
    Mazzaro, C.
    Ferri, C.
    Baldini, C.
    De Vita, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (01) : 80 - 83
  • [2] Fibronectin gene polymorphisms in HCV related type II mixed cryoglobulinemia: risk of development of B-cell lymphoma
    Elsaadany, Zainab
    Farawela, Hala
    Fouad, Rabab
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S26 - S26
  • [3] Fibronectin gene polymorphisms in HCV related type II mixed cryoglobulinemia: risk of development of B-cell lymphoma
    Farawela H.
    Fouad R.
    Zahran N.
    Madkour B.
    El-Saadany Z.
    Toimaa S.
    Mamdouh S.
    El-Kiat H.
    [J]. Comparative Clinical Pathology, 2018, 27 (5) : 1389 - 1395
  • [4] Lymphoproliferation in type II mixed cryoglobulinemia
    Monteverde, A
    Ballare, M
    Bertoncelli, MC
    Zigrossi, P
    Sabattini, E
    Poggi, S
    Pileri, S
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 : S141 - S147
  • [5] Essential mixed cryoglobulinemia type II
    Rozin, A. P.
    Lewin, M.
    Braun-Moscovici, Y.
    Itzhak, O. B.
    Bergman, R.
    Balbir-Gurman, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (03) : 329 - 332
  • [6] Type II mixed cryoglobulinemia treated with fludarabine
    Enzenauer, RJ
    Judson, PH
    [J]. JOURNAL OF RHEUMATOLOGY, 1996, 23 (04) : 794 - 795
  • [7] Rituximab for the treatment of type II mixed cryoglobulinemia
    Zaja, F
    Russo, D
    Fuga, G
    Patriarca, F
    Ermacora, A
    Baccarani, M
    [J]. HAEMATOLOGICA, 1999, 84 (12) : 1157 - 1158
  • [8] Cotrimoxazole induced mixed type II cryoglobulinemia
    Leclercq, P.
    Frippiat, F.
    Lambermont, B.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (04) : 303 - 304
  • [9] Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes
    Fabris, M.
    Quartuccio, L.
    De Re, V.
    Pozzato, G.
    Mazzaro, C.
    Tavoni, A.
    Ferri, C.
    Salvin, S.
    Lerussi, A.
    Fabro, C.
    Bombardieri, S.
    De Vita, S.
    [J]. REUMATISMO, 2008, 60 (01) : 28 - 34
  • [10] Rituximab for the treatment of type II mixed cryoglobulinemia.
    Zaja, F
    De Vita, S
    Sperotto, A
    Sacco, S
    Mazzaro, C
    Tomadini, V
    Ferraccioli, G
    Baccarani, M
    Fanin, R
    [J]. BLOOD, 2003, 102 (11) : 54B - 54B
12345